These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 10916847

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sleep attacks and Parkinson's disease treatment.
    Ferreira JJ, Galitzky M, Montastruc JL, Rascol O.
    Lancet; 2000 Apr 15; 355(9212):1333-4. PubMed ID: 10776750
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Developments in the treatment of parkinsonism.
    Calne DB.
    N Engl J Med; 1976 Dec 16; 295(25):1433-4. PubMed ID: 989886
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
    Libman I, Gawel MJ, Riopelle RJ, Bouchard S.
    Can J Neurol Sci; 1987 Nov 16; 14(4):576-80. PubMed ID: 3319120
    [Abstract] [Full Text] [Related]

  • 14. [Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case].
    Debove P, Simon F, Vaylet F, Renard JL, L'Her P.
    Ann Med Interne (Paris); 1998 Apr 16; 149(3):167-71. PubMed ID: 11490541
    [Abstract] [Full Text] [Related]

  • 15. [Stage-adjusted treatment of idiopathic Parkinson syndrome].
    Ludin HP.
    Wien Med Wochenschr; 1995 Apr 16; 145(13):294-8. PubMed ID: 7571654
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Current and future approaches to therapy.
    Birkmayer W, Birkmayer JD.
    Adv Neurol; 1987 Apr 16; 45():511-2. PubMed ID: 3103393
    [No Abstract] [Full Text] [Related]

  • 18. The response of "de novo" Parkinson's disease patients to bromocriptine in a "low and slow" regimen is predictive for prognosis.
    Sampaio C, Coelho T, Castro-Caldas A, Bastos-Lima A, Levy A.
    J Neural Transm Suppl; 1995 Apr 16; 45():197-202. PubMed ID: 8748626
    [Abstract] [Full Text] [Related]

  • 19. [Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
    Alegre M, Noé E, Martínez Lage JM.
    Neurologia; 1997 Nov 16; 12(9):429. PubMed ID: 9471184
    [No Abstract] [Full Text] [Related]

  • 20. Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
    Champagne S, Coste E, Peyrière H, Nigond J, Mania E, Pons M, Hillaire-Buys D, Balmes P, Blayac JP, Davy JM.
    Ann Pharmacother; 1999 Oct 16; 33(10):1050-4. PubMed ID: 10534217
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.